SCHEMBL7790183

SCHEMBL7790183

O=C(CCCNC(=O)O)Cc1cccc(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.46
ERBB2 P04626 5/20 0.46
LMNA P02545 1/20 0.46
HSP90AA1 P07900 1/20 0.46
GLS O94925 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 1/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
ATM Q13315 1/20 0.43
SIGMAR1 Q99720 2/20 0.43
TMEM97 Q5BJF2 1/20 0.43
FFAR1 O14842 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
CNR1 P21554 1/20 0.40
GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718010 0.83 ATM (0.60) LMNANPC1RAB9AATM
SCHEMBL1794493 0.82 NPC1 (0.52) HSP90AA1NPC1RAB9ASIGMAR1CNR1
SCHEMBL6477205 0.81 HSP90AA1 (0.55) LMNAHSP90AA1NPC1RAB9ACNR1
SCHEMBL3832809 0.79 GLS (0.46) EGFRERBB2GLSSIGMAR1FFAR1
SCHEMBL7796993 0.79 ALDH1A1 (0.53) LMNANPC1RAB9ASIGMAR1
SCHEMBL901955 0.79 NPC1 (0.63) NPC1RAB9ACA12CA1CA2
SCHEMBL1448505 0.78 EGFR (0.53) EGFRERBB2GLSNPC1CA12
SCHEMBL5950139 0.76 EGFR (0.49) EGFRERBB2GLSNPC1
SCHEMBL3008052 0.75 EGFR (0.48) EGFRERBB2GLSNPC1RAB9A
SCHEMBL1750050 0.75 CYP1A2 (0.58) EGFRERBB2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1159260-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000055124-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed